Connection

MICHAEL JAMES OVERMAN to Promoter Regions, Genetic

This is a "connection" page, showing publications MICHAEL JAMES OVERMAN has written about Promoter Regions, Genetic.
  1. Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer. Ann Oncol. 2018 01 01; 29(1):139-144.
    View in: PubMed
    Score: 0.090
  2. Association of CHFR promoter methylation with disease recurrence in locally advanced colon cancer. Clin Cancer Res. 2011 Jul 01; 17(13):4531-40.
    View in: PubMed
    Score: 0.056
  3. Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer. Clin Colorectal Cancer. 2021 06; 20(2):137-147.e1.
    View in: PubMed
    Score: 0.027
  4. Facile profiling of molecular heterogeneity by microfluidic digital melt. Sci Adv. 2018 09; 4(9):eaat6459.
    View in: PubMed
    Score: 0.024
  5. Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer. Br J Cancer. 2016 06 14; 114(12):1352-61.
    View in: PubMed
    Score: 0.020
  6. High-level microsatellite instability in appendiceal carcinomas. Am J Surg Pathol. 2013 Aug; 37(8):1192-200.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.